Related Experiment Videos
Identification of frequent cytogenetic aberrations in hepatocellular carcinoma using gene-expression microarray data
Joseph J Crawley1, Kyle A Furge
1Bioinformatics Program, Van Andel Research Institute, Grand Rapids, MI 49503, USA.
Genome Biology
|January 23, 2003
Summary
Comparative Genomic Microarray Analysis (CGMA) identifies cytogenetic changes in hepatocellular carcinoma (HCC) by analyzing gene expression. This method offers a practical alternative to traditional CGH, revealing new genetic regions and candidate genes in HCC.
Area of Science:
- Genomics
- Cancer Research
- Molecular Biology
Background:
- Hepatocellular carcinoma (HCC) is a major global cause of cancer mortality.
- Cytogenetic abnormalities are common in HCC, indicating the involvement of oncogenes or tumor suppressors.
- Identifying specific genes driving these changes has been challenging.
Purpose of the Study:
- To apply Comparative Genomic Microarray Analysis (CGMA) to HCC gene-expression profiles.
- To identify regions of frequent cytogenetic change in HCC.
- To identify genes with misregulated expression within these altered regions.
Main Methods:
- Analysis of 104 HCC gene-expression microarray profiles using CGMA.
- CGMA predicts cytogenetic changes by detecting regional gene-expression biases.
- Comparison of CGMA findings with previous comparative genomic hybridization (CGH) studies.
Main Results:
- CGMA identified 13 regions of frequent cytogenetic change in HCC samples.
- Ten of these regions were previously identified by CGH.
- Three novel regions of cytogenetic change (+5q, +12q, +19p) were identified by CGMA.
- Expression levels of genes within these regions were examined.
Conclusions:
- CGMA is a practical alternative to CGH for predicting cytogenetic changes using gene-expression data.
- CGMA can effectively identify candidate genes within cytogenetically abnormal regions in HCC.
- This approach aids in understanding the genetic drivers of HCC.